Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rattus norvegicus strain:wistar | breed:Inbreed

ABSTRACT: Serum microRNA as a potential biomarker for the diagnosing of Parkinson Disease using computational approaches and animal studies

PROVIDER: PRJNA1033624 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26623618.fastq.gz	Fastqsanger.gz
	SRR26623619.fastq.gz	Fastqsanger.gz
	SRR26623620.fastq.gz	Fastqsanger.gz
	SRR26623624.fastq.gz	Fastqsanger.gz
	SRR26623625.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 9

Similar Datasets

Project description:biomarkers in platelets for diagnosing Parkinson

| PRJNA732803 | ENA

Circulating miRNAs of acetaminophen-overdosed patients

Project description:Drug-induced liver injury (DILI) is a leading cause of acute liver failure and the major reason for withdrawal of drugs from the market. Preclinical evaluation of drug candidates has failed to detect about 40% of potentially hepatotoxic compounds in humans. At the onset of liver injury in humans, currently used biomarkers have difficulty differentiating severe DILI from mild, and/or predict the outcome of injury for individual subjects. Therefore, new biomarker approaches for predicting and diagnosing DILI in humans are urgently needed. Recently, circulating microRNAs (miRNAs) such as miR-122 and miR-192 have emerged as promising biomarkers of liver injury in preclinical species and in DILI patients. In this study, we focused on examining global circulating miRNA profiles in serum samples from subjects with liver injury caused by accidental acetaminophen (APAP) overdose. Upon applying next generation high-throughput sequencing of small RNA libraries, we identified 36 miRNAs, including 3 novel miRNA-like small nuclear RNAs, which were enriched in the serum of APAP overdosed subjects. The set comprised miRNAs that are functionally associated with liver-specific biological processes and relevant to APAP toxic mechanisms. Although more patients need to be investigated, our study suggests that profiles of circulating miRNAs in human serum might provide additional biomarker candidates and possibly mechanistic information relevant to liver injury.

2014-11-28 | GSE59565 | GEO

Serum is preferable to plasma for circulating exosomal microRNA biomarker discovery studies

Project description:Serum is preferable to plasma for circulating exosomal microRNA biomarker discovery studies

| PRJNA598665 | ENA

Development of blood biomarkers that distinguish pancreatic cancer from biliary tract cancer

Project description:We have developed a method for diagnosing pancreatic cancer and bile duct cancer based on miRNA expression information in the circulating blood. 2565 miRNAs in 426 serum samples were analyzed.

2023-06-30 | GSE212211 | GEO

Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson’s disease

Project description:Our study provides a valuable resource for small RNA profiles in normal, iRBD and PD plasma EVs, and showed that the EV-miRNAs have the potential to serve as biomarker for diagnosing the PD patients and iRBD patients.

2024-01-16 | GSE166070 | GEO

Multiomic approaches for thyroid cancer diagnosis

Project description:Thyroid cancer is a common endocrine malignancy; however, its diagnosis is not straightforward. The current gold standard for diagnosing thyroid cancer is fine needle aspiration biopsy (FNAB), but when cytological analysis does not provide viable results or samples belong to less defined categories of diagnosis, patients are often referred to diagnostic surgery. Given that not all these nodules require removal, nor all of them are malignant, patients would not necessarily require surgery had the initial FNAB diagnosis been more conclusive. There is therefore a lack of reliable and specific biomarkers for thyroid cancer malignancy, that can complement and improve the current diagnosing methods. “Omics” approaches have gained much attention in the last decade in the field of biomarker discovery for diagnostic and prognostic characterization of various pathophysiological conditions. In this project, proteomics and metabolomics approaches were applied to the same thyroid nodules from patients with benign and malignant lesions. Tissue analysis provided several interesting biomarkers by both proteomics and metabolomics. The combination of these results demonstrated the high energetic and biomass demand of cancer cells, as well as a biomarker panel including 2 free peptides and 2 proteins with high sensitivity and specificity. Together, these results have contributed to increasing the knowledge of thyroid cancer phenotype and corresponding biochemical profiles, as well as providing potential biomarkers for malignancy, and improving diagnostic methodologies.

2023-10-24 | PXD035583 | Pride

Project description:Animal liver omics studies

| PRJNA1155869 | ENA

Homo sapiens

Project description:Circulating microRNAs: a novel potential biomarker for diagnosing acute aortic dissection

| PRJNA357550 | ENA

Homo sapiens

Project description:University of Washington cerebrospinal fluid biomarker study for Parkinson disease

| PRJNA281516 | ENA

Homo sapiens

Project description:University of Washington cerebrospinal fluid biomarker study for Parkinson disease

| PRJNA281517 | ENA